Advertisement
Canada markets close in 58 minutes
  • S&P/TSX

    21,981.38
    +96.00 (+0.44%)
     
  • S&P 500

    5,109.52
    +61.10 (+1.21%)
     
  • DOW

    38,304.07
    +218.27 (+0.57%)
     
  • CAD/USD

    0.7324
    +0.0001 (+0.01%)
     
  • CRUDE OIL

    83.76
    +0.19 (+0.23%)
     
  • Bitcoin CAD

    87,451.70
    -865.97 (-0.98%)
     
  • CMC Crypto 200

    1,333.93
    -62.60 (-4.48%)
     
  • GOLD FUTURES

    2,352.10
    +9.60 (+0.41%)
     
  • RUSSELL 2000

    2,003.55
    +22.43 (+1.13%)
     
  • 10-Yr Bond

    4.6690
    -0.0370 (-0.79%)
     
  • NASDAQ

    15,944.50
    +332.74 (+2.13%)
     
  • VOLATILITY

    15.07
    -0.30 (-1.95%)
     
  • FTSE

    8,139.83
    +60.97 (+0.75%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • CAD/EUR

    0.6838
    +0.0017 (+0.25%)
     

Here's Why Cronos Still Isn't a Buy, Despite Posting a Profit and Boasting $1 Billion in Cash

Here's Why Cronos Still Isn't a Buy, Despite Posting a Profit and Boasting $1 Billion in Cash

Cannabis investors sometimes have to take earnings results with a grain of salt. Relying just on sales and net income figures can lead to incorrect conclusions. Cronos has recorded a positive net income figure in each of its past five quarterly results.